167 related articles for article (PubMed ID: 24055582)
1. Clinical performance of a multivariate index assay for detecting early-stage ovarian cancer.
Longoria TC; Ueland FR; Zhang Z; Chan DW; Smith A; Fung ET; Munroe DG; Bristow RE
Am J Obstet Gynecol; 2014 Jan; 210(1):78.e1-9. PubMed ID: 24055582
[TBL] [Abstract][Full Text] [Related]
2. Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay.
Bristow RE; Smith A; Zhang Z; Chan DW; Crutcher G; Fung ET; Munroe DG
Gynecol Oncol; 2013 Feb; 128(2):252-9. PubMed ID: 23178277
[TBL] [Abstract][Full Text] [Related]
3. Impact of a multivariate index assay on referral patterns for surgical management of an adnexal mass.
Bristow RE; Hodeib M; Smith A; Chan DW; Zhang Z; Fung ET; Tewari KS; Munroe DG; Ueland FR
Am J Obstet Gynecol; 2013 Dec; 209(6):581.e1-8. PubMed ID: 23942039
[TBL] [Abstract][Full Text] [Related]
4. How relevant are ACOG and SGO guidelines for referral of adnexal mass?
Dearking AC; Aletti GD; McGree ME; Weaver AL; Sommerfield MK; Cliby WA
Obstet Gynecol; 2007 Oct; 110(4):841-8. PubMed ID: 17906018
[TBL] [Abstract][Full Text] [Related]
5. Preoperative assessment of ovarian tumors using a modified multivariate index assay.
Abdurrahman HA; Jawad AK; Alalalf SK
J Ovarian Res; 2018 May; 11(1):41. PubMed ID: 29843758
[TBL] [Abstract][Full Text] [Related]
6. Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses.
Coleman RL; Herzog TJ; Chan DW; Munroe DG; Pappas TC; Smith A; Zhang Z; Wolf J
Am J Obstet Gynecol; 2016 Jul; 215(1):82.e1-82.e11. PubMed ID: 26970494
[TBL] [Abstract][Full Text] [Related]
7. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
8. Costs, effectiveness, and workload impact of management strategies for women with an adnexal mass.
Havrilesky LJ; Dinan M; Sfakianos GP; Curtis LH; Barnett JC; Van Gorp T; Myers ER
J Natl Cancer Inst; 2015 Jan; 107(1):322. PubMed ID: 25515232
[TBL] [Abstract][Full Text] [Related]
9. Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.
Miller RW; Smith A; DeSimone CP; Seamon L; Goodrich S; Podzielinski I; Sokoll L; van Nagell JR; Zhang Z; Ueland FR
Obstet Gynecol; 2011 Jun; 117(6):1298-1306. PubMed ID: 21555961
[TBL] [Abstract][Full Text] [Related]
10. Validation of serum biomarkers for detection of early-stage ovarian cancer.
Nosov V; Su F; Amneus M; Birrer M; Robins T; Kotlerman J; Reddy S; Farias-Eisner R
Am J Obstet Gynecol; 2009 Jun; 200(6):639.e1-5. PubMed ID: 19285648
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors.
Ueland FR; Desimone CP; Seamon LG; Miller RA; Goodrich S; Podzielinski I; Sokoll L; Smith A; van Nagell JR; Zhang Z
Obstet Gynecol; 2011 Jun; 117(6):1289-1297. PubMed ID: 21606739
[TBL] [Abstract][Full Text] [Related]
12. The effect of ovarian imaging on the clinical interpretation of a multivariate index assay.
Goodrich ST; Bristow RE; Santoso JT; Miller RW; Smith A; Zhang Z; Ueland FR
Am J Obstet Gynecol; 2014 Jul; 211(1):65.e1-65.e11. PubMed ID: 24530816
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
[TBL] [Abstract][Full Text] [Related]
14. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ
J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136
[TBL] [Abstract][Full Text] [Related]
15. Relapse and survival in early-stage ovarian cancer.
Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population.
Moore LE; Fung ET; McGuire M; Rabkin CC; Molinaro A; Wang Z; Zhang F; Wang J; Yip C; Meng XY; Pfeiffer RM
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1641-6. PubMed ID: 16985025
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer risk assessment: a tool for preoperative assessment.
Ronco DA; Manahan KJ; Geisler JP
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):325-9. PubMed ID: 21802191
[TBL] [Abstract][Full Text] [Related]
18. Validation of referral guidelines for women with pelvic masses.
Im SS; Gordon AN; Buttin BM; Leath CA; Gostout BS; Shah C; Hatch KD; Wang J; Berman ML
Obstet Gynecol; 2005 Jan; 105(1):35-41. PubMed ID: 15625139
[TBL] [Abstract][Full Text] [Related]
19. Applicability of the modified ACOG/SGO referral criteria for adnexal mass within a limited-resource setting.
Battarbee A; Strohl A; Zimmerman L; Patel A; Burtch R
Int J Gynaecol Obstet; 2017 Jan; 136(1):53-57. PubMed ID: 28099697
[TBL] [Abstract][Full Text] [Related]
20. Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer.
Nakae M; Iwamoto I; Fujino T; Maehata Y; Togami S; Yoshinaga M; Douchi T
J Obstet Gynaecol Res; 2006 Jun; 32(3):309-14. PubMed ID: 16764622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
